BREEZE: Open‐label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™in patients with pulmonary arterial hypertension. - Spikes, Leslie A.; Bajwa, Abubakr A.; Burger, Charles D.; Desai, Sapna V.; Eggert, Michael S.; El‐Kersh, Karim A.; Fisher, Micah R.; Johri, Shilpa; Joly, Joanna M.; Mehta, Jinesh; Palevsky, Harold I.; Ramani, Gautam V.; et al. (Pulmonary Circulation, 2022)